Recently, Baboota et al. reported a strong association between increase in fasting insulin levels, as well as in degree of IR, and hepatic CS in obese NAFLD/NASH patients (13). The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.